← Back to companies
Edgewise Therapeutics
0 open
Boulder, Colorado, United StatesFounded 2017114+ employees$738.5M raisedIPOEWTX
Last round: post ipo equity · $200M · Apr 2025(6 rounds total)
Founded by Alan Russell, Badreddin Edris, Peter Thompson
Backed by(26 investors)
Novo HoldingsU.S. Venture PartnersViking Global InvestorsParadigm BioCapital AdvisorsBraidwellRA Capital ManagementOrbiMedJanus Henderson InvestorsPerceptive AdvisorsSofinnova InvestmentsMPM BioImpactInvusDriehaus Capital ManagementWellington ManagementCitadel
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.
Open Positions at Edgewise Therapeutics (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Edgewise Therapeutics?
